SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-034103 from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: April 18, 2024 · CIK: 0001711786 · Accession: 0001213900-24-034103

AI Filing Summary & Sentiment

File numbers found in text: 333-278620

Date
April 18, 2024
Author
Not clearly detected
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

590 Madison Ave., 21st Floor

New York, NY 10022

April 18, 2024

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Chris Edwards

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-1

File No. 333-278620

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Friday, April 19, 2024, or as soon thereafter as possible.

Please notify Emily Mastoloni of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 896-0675 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Hoth Therapeutics,
Inc.

590 Madison Ave., 21st Floor

New York, NY 10022

April 18, 2024

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Chris Edwards

    Re:
    Hoth Therapeutics, Inc.

    Registration Statement on Form S-1

    File No. 333-278620

Ladies and Gentlemen:

Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Hoth Therapeutics, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 5:00 p.m., Eastern Standard Time, on Friday, April 19, 2024, or as soon thereafter as possible.

Please notify Emily Mastoloni
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 896-0675 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.

    HOTH THERAPEUTICS, INC.

    By:
    /s/ Robb Knie

    Name:
    Robb Knie

    Title:
    Chief Executive Officer